Evidence map›Paper›PMID 41174092›Full record

ArticlePsychopharmacology2025

Methamphetamine and α-pyrrolidinopentiophenone (α-PVP) intravenous self-administration in female and male rats.

Arnold Gutierrez, Yanabel Grant, Sophia A Vandewater, Michael A Taffe

Abstract read
In one paragraph

Article in Psychopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Arnold GutierrezDepartment of Psychiatry, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA. agutierrez98@utep.edu.
Yanabel GrantDepartment of Psychiatry, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA.
Sophia A VandewaterDepartment of Psychiatry, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA.
Michael A TaffeDepartment of Psychiatry, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA. mtaffe@ucsd.edu.

Funding

UCSD/SDSU IRACDAK12GM068524 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TREJO, JOANN · 2003 to 2025
$24.4M
Dissecting the Abuse Liability of Synthetic Cathinone StimulantsR01DA042211 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MICHAEL A. TAFFE · 2016 to 2026
$3.6M
NIDA NIH HHS R01 DA042211NIGMS NIH HHS K12 GM068524NIH HHS R01 DA042211
6 · The paper itself

Abstract

rationaleStimulant drug users vary in their substance of choice and may, in some cases, switch up their preferred substance based on availability, cost or other factors. Poly-substance use is rarely assessed in rodent models of drug seeking.

objectivesTo determine if training drug alters the apparent reinforcing properties of methamphetamine (MA) and α-pyrrolidinopentiophenone (α-PVP).

methodsFemale and male Wistar rats (N = 8 per group) were trained in the intravenous self-administration (IVSA) of α-PVP or MA. The impact of dose substitution (0.0125, 0.0250, 0.100, 0.300 mg/kg/infusion) for each training drug was then assessed in all groups under FR and Progressive Ratio schedules of reinforcement.

resultsMale and female rats obtained similar numbers of infusions of MA (0.05 mg/kg/infusion) and of α-PVP (0.05 mg/kg/infusion) during acquisition, however more infusions of α-PVP than of MA were obtained by each sex. Mean lever discrimination ratios exceeded 80% on the drug-associated lever within 5 training sessions for α-PVP groups but were not consistently at this level for either MA group. Drug potency was similar across groups but was less effective in the MA-trained males.

conclusionsInterpretations of sex differences in the acquisition of drug IVSA require caution when dose is not varied across or within group. This study also further confirms that the apparent efficacy of a drug as a reinforcer depends at least partially on the behavioral antecedents, including the identity of the drug used for initial IVSA acquisition.

Indexed as

Bath saltsCathinonesPoly-drugReinforcementRewardRodent

Identifiers

PMID41174092
PMCPMC12823102

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.